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Abstract
Background: Variability in patient-reported outcomes of psychological treatments has been partly attributed to therapists –
a phenomenon commonly known as therapist effects. Meta-analytic reviews reveal wide variation in therapist-attributable
variability in psychotherapy outcomes, with most studies reporting therapist effects in the region of 5% to 10% and some
finding minimal to no therapist effects. However, all except one study to date have been conducted in high-intensity or
mixed intervention groups; therefore, there is scarcity of evidence on therapist effects in brief low-intensity psychological
interventions.
Objective: To examine therapist effects in low-intensity interventions for depression and anxiety in a naturalistic setting.
Data and Analysis: Session-by-session data on patient-reported outcome measures were available for a cohort of 1,376
primary care psychotherapy patients treated by 38 therapists. Outcome measures included PHQ-9 (sensitive to depression)
and GAD-7 (sensitive to general anxiety disorder) measures. Three-level hierarchical linear modelling was employed to
estimate therapist-attributable proportion of variance in clinical outcomes. Therapist effects were evaluated using the intra-
cluster correlation coefficient (ICC) and Bayesian empirical predictions of therapist random effects. Three sensitivity analyses
were conducted: 1) using both treatment completers and non-completers; 2) a sub-sample of cases with baseline scores
above the conventional clinical thresholds for PHQ-9 and GAD-7; and 3) a two-level model (using patient-level pre- and
post-treatment scores nested within therapists).
Results: The ICC estimates for all outcome measures were very small, ranging between 0% and 1.3%, although most were
statistically significant. The Bayesian empirical predictions showed that therapist random effects were not statistically
significantly different from each other. Between patient variability explained most of the variance in outcomes.
Conclusion: Consistent with the only other study to date in low intensity interventions, evidence was found to suggest
minimal to no therapist effects in patient-reported outcomes. This draws attention to the more prominent source of
variability which is found at the between-patient level.
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Introduction
Variability in outcomes of psychological treatments has been
partly attributed to therapists – a phenomenon commonly known
as therapist effects (TE). However, despite a wealth of research
over more than 20 years, the extent to which TE determine
psychotherapy outcomes remains a widely debated topic [1–10].
TE may be an important factor to consider when evaluating
observed differences between psychotherapy treatments which
may be partly explained by differences in the mix of therapists
[6,11]. For example, in a sample of severely depressed patients in
the National Institute of Mental Health Treatment of Depression
Collaborative Research Program (NIMH TDCRP), Kim et al.
(2006) found that observed treatment differences between two
psychotherapy interventions disappeared once therapists effects
were taken into account [6]. These observations have led some
researchers to conclude that ignoring TE in clinical outcome
studies may lead to inaccurate effect size estimates and hence
result in misleading conclusions [12,13]. Therapist effects are also
be important in understanding the variability in patient-reported
outcomes that can partly be explained by heterogeneity of
therapists (4, 5).
A prominent source of debate is the wide variation in TE
estimates across studies. Some studies report strong evidence of TE
(e.g. [4,6,9,14,15], whilst other studies demonstrate negligible or
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statistically non-significant TE (e.g. [2,7,10,16,17]. A meta-analysis
of 15 studies involving a heterogeneous mix of patient groups,
psychological treatments, therapist numbers and patient sample
sizes found that TE accounted for an estimated 8.6% (range 0% to
almost 50%) of the variability in patient outcomes following
therapy [2]. More recent reviews have reported TE estimates in
the range of 5% to 10% [6,18]. This wide variability across studies
raises questions about the relative importance of TE in psycho-
therapy and the possible explanations for such variability.
Potential explanations for this variability can be broadly divided
into three areas: methodological characteristics (study design and
analysis), patient and therapist characteristics, and treatment
characteristics. Possibly the most contentious issue in this field
concerns the methods used to estimate TE. Many authors have
argued that the type of statistical modelling applied in these studies
can directly influence the estimated therapist effects (e.g.
[8,14,19,20]. A good example of this is the re-analysis of the
NIMH TDCRP data conducted independently by two research
groups, where significant TE of approximately 8% were shown by
one group [6], whilst the other group reported little to no evidence
of therapist effects [7]. Although both groups analysed data using
hierarchical linear modelling (HLM), they differed in how this
method was applied. Kim and colleagues (2006) applied a two-
level HLM method (patients nested within therapists) which
analyses pre-treatment and post-treatment outcome scores only
[6], and Elkin and colleagues (2006) used a three-level HLM
method (session scores nested within patients, nested within
therapist) which analyses longitudinal outcome data to include
the effect of change over time [7].
Some authors have argued that the magnitude of TE may vary
according to the study design, and can only be reliably estimated
from large-scale naturalistic studies [14,19]. Many TE studies have
been conducted within the confines of well-controlled efficacy
studies, using a more homogenous patient population and smaller
numbers of therapists and patients (e.g. [1,6,7,21]. Such studies
have tended to produce mixed results (e.g. [6,7]). On the other
hand, naturalistic studies often include heterogeneous patient
populations with larger numbers of both patients and therapists,
thus more closely representing routine clinical practice (e.g.
[9,10,14,15]). Nevertheless, naturalistic studies have also produced
mixed results to date. Although three studies report TE of between
4% and 8% [9,14,15], one recent study reported only minimal TE
of between 0% and 2% [10]. An additional and potentially
important methodological characteristic of these studies concerns
the outcome measure used to estimate TE. Some authors have
argued that the magnitude of TE estimates may depend on
whether the outcome is a generic measure of psychological distress
or a disorder-specific measure, and whether outcomes are self-
reported or therapist-rated [7,10]. However, a recent meta-
analytic review demonstrated mixed findings for studies that used
both the same disorder specific measures (e.g. BDI), more generic
measures of distress (e.g. OQ-45) or therapist-rated measures (e.g.
GAF) [18].
Besides methodological characteristics, it is possible that the
characteristics of the patients and therapists included in a
particular study may determine the size and significance of
observed therapist effects. Kim and colleagues (2006), for example,
found that the magnitude of TE in the NIMH TDCRP was
correlated with baseline level of severity [6]. In a meta-analytic
investigation, Crits-Christoph and colleagues (1991), found that
the use of a treatment manual and more experienced therapists
were associated with small TE, whereas more inexperienced
therapists and no treatment manual were associated with larger
TE [2]. Other studies suggest that the existence of outlier
therapists can influence the size of TE, with TE being attenuated
or eliminated when outlier therapists are removed (e.g. [6,21].
Similarly, it is possible that outlier patients may influence the
magnitude of TE in a given sample. Saxon and Barkham (2012),
for example, argue that very impaired, complex cases inflate TE
[22], which may result in smaller therapist effects in samples
without this level of case complexity.
Although there is still uncertainty about the extent to which TE
are important determinants of therapeutic outcomes, some clear
methodological lessons can be drawn from the literature. The
magnitude of observed TE is likely to be dependent on a number
of factors including the heterogeneity of the patient population
(e.g. case-mix), differences in baseline severity of the disorder, the
number of therapists involved and patient sample size [20,22].
Precise TE estimates are more likely to be derived from large
naturalistic samples including at least 30 therapists [20]. In
addition to controlling for factors that may influence TE,
researchers have argued that the use of statistical methods such
as multilevel modelling is more appropriate for such data, since
they better reflect the natural structure of variability in outcomes
(e.g. patients nested within individual therapists) and allow for a
partitioning of outcome variance at the patient and therapist levels
[22]. In addition, random effects (or mixed) analyses (rather than
only fixed effects analyses) better facilitate the computation of
standardised therapist variance estimates and the generalisation of
findings as relevant to the wider population of therapists [18].
While the current literature provides some insight into the
relevance of methodological and patient-therapist characteristics,
what has been less studied is the influence of treatment
characteristics. Nearly all previous therapist-effect studies have
focused on conventional psychotherapeutic interventions, such as
cognitive-behaviour therapy (e.g. [4,6,7,10]), interpersonal therapy
[6,7] and psychodynamic therapy (see [2]). Only one previous
study has examined therapist effects in brief low-intensity
psychological interventions. Almlo˝v et al. (2011) found little
evidence for TE in a study involving low-intensity guided
internet-delivered Cognitive Behaviour Therapy [23]. The authors
suggest that this is partly explained by similarity of therapists in
terms of level of experience and therapeutic orientation. The
interpretation of these results, however, is limited by the small
patient sample size (119 patients drawn from three individual
studies) and small therapist numbers (N = 8).
Brief low-intensity psychological interventions have a number of
broad features that differentiate them from more traditional, high-
intensity psychotherapeutic interventions [24,25]. Low-intensity
interventions are typically less complex, involve a reduced level of
contact with the person receiving treatment, and often use novel
forms of delivery (e.g., telephone delivery, computerised Cognitive
Behaviour Therapy, provision of self-help material, group
treatment) [25]. In addition to the nature of the treatment itself,
low-intensity interventions are likely to differ from high-intensity
treatments in terms of who provides and who receives the
treatment. Low-intensity treatments are typically intended for
patients with mild to moderate symptoms and less complex
presentations; they are also designed to be delivered by
professionals or para-professionals with less extensive training
who are likely to have similar level of experience [26]. These
characteristics of low-intensity therapy may influence the size and
significance of therapist effects. However, there is paucity of
evidence on therapist effects in low-intensity psychotherapy.
Therefore, the main aim of the current study is to estimate TE
in a large naturalistic treatment sample of brief low-intensity
treatments for people presenting with common mental health
problems such as depression and anxiety.
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Methods
Ethics statement
Use of anonymous clinical records for this study was approved
by an English National Health Service (NHS) research ethics
committee, on 15 September 2010, reference 10/H1306/68.
Patients provided verbal consent at the earliest contact point with
the service which was over the telephone, hence verbal consent
was appropriate. Patients were asked whether they agreed to allow
their anonymous clinical records to be used for research and audit
purposes. Verbal consent was then recorded in the electronic
patient clinical record. Anonymous datasets were extracted from
electronic clinical records for audit/research purposes, which
excluded non-consenting patients. This method was approved by
the reviewing NHS ethics committee.
Study population
This study was based on routinely collected session-by-session
patient reported outcome measures (PROMS) for patients
accessing treatment for depression and anxiety disorders in a
primary care mental health service in Leeds, England. These data
are specifically drawn from a cohort of patients who received low
intensity (LI) evidence-based interventions recommended by
national guidelines [27,28] and delivered as part of the English
Improving Access to Psychological Therapies (IAPT) programme
[29]. These interventions included guided self-help based on
cognitive behavioural therapy (CBT) principles, one-to-one and
group based psycho-education about common mental disorders,
and computerised CBT with support by a mental health
professional. Such interventions are considered ‘low intensity’
given their brief length (typically under 8 sessions, although a small
proportion of patients may have more sessions), and because they
are delivered by qualified therapists whose training is briefer and
less extensive than that of psychotherapists or clinical psycholo-
gists. Therapists in this service completed a standard, 1-year post-
graduate qualification specific to the delivery of low intensity
treatments and following a national curriculum (e.g. see [26,30]).
Patients in this cohort were either directly referred to the service
by general medical practitioners or encouraged to self-refer.
Following referral, all patients attended a 45 minute screening
interview with a qualified mental health practitioner. ICD-10
based primary diagnoses were derived from these interviews
supplemented by validated case-finding questionnaires. This
assessment was used to determine suitability for LI interventions
on the basis of a positive screen on depression and/or anxiety
measures (described below), and on idiographic data gathered to
assess the presenting problem, patient goals and risk factors.
Following national guidelines [27,28], those patients with mild-to-
moderate symptoms and functional impairment were deemed
suitable for LI interventions and were sequentially allocated to the
first available therapist. Although for a minority of patients, their
preferences did influence the location of treatment and gender of
therapist, there was virtually no selection on the part of therapists.
Patients who did not meet criteria for LI interventions (e.g. those
with severe, chronic and/or complex conditions) and those who
did not improve after LI treatment were ‘stepped up’ to more
intensive and lengthier psychotherapy in the service; however, this
study only focuses on the sample of patients who received
treatment with a therapist qualified to deliver low intensity
interventions (including those who were later stepped-up).
Outcome measures
Data on two commonly used PROMS was available. The
Patient Health Questionnaire (PHQ-9) is a nine item self-
completed questionnaire commonly used to screen for major
depression [31]. This measure is reported to have adequate
sensitivity (88%) and specificity (88%) using a cut-off score $ 10
[31]. The Generalized Anxiety Disorder scale (GAD-7) is a seven
item questionnaire originally developed to detect GAD, although
adequate sensitivity (77%) and specificity (82%) estimates have
been reported for its capacity to screen for other anxiety disorders
including social phobia, post-traumatic stress disorder and panic
disorder using a cut-off $ 8 [32]. Both measures have been
extensively validated and widely used in primary care settings
across several countries [33]. Each item in these questionnaires is
scored on a 0-3 scale and the scores are summed to give an overall
score (range for PHQ-9 = 0-27; GAD-7 = 0-21) with a higher score
indicating more severe symptoms.
Statistical analysis
Hierarchical structure. The IAPT data structure is hierar-
chical and consists of three-levels: level 1 is the ‘visit-level’ for
session-by-session PHQ-9 and GAD-7 scores for each patient (with
visit 1 being the baseline session), level 2 is the ‘patient-level’
representing scores nested within patients, and level 3 is the
‘therapist-level’ representing patients nested within therapists.
Three-level hierarchical linear mixed (HLM) models were used
for primary analysis to evaluate longitudinal variation in patient-
reported outcomes based on PHQ-9 and GAD-7 scores. HLM
models decompose total variation in health outcomes into variance
components attributable to each level, in particular, the therapist-
level (level 3). We used unconditional and conditional HLM
models for this purpose; the unconditional HLM model is a
random intercept model that does not include any covariates
(explanatory variables) while the conditional model includes
patient-level covariates and decomposes the remaining variation
into variance components. For the primarily analysis, data from all
patients who had completed therapy was used. A sensitivity
analysis included full sample of treatment completers and non-
completers (i.e. those who dropped out or were stepped-up to
more intense and lengthier psychotherapy). HLM models were
separately implemented for PHQ-9 and GAD-7 outcome mea-
sures. The analysis was conducted in Stata version 13.1 (Stata
Corporation, College Station TX, USA). The statistical models
used in the analysis are described in detail below.
Unconditional model. Following Raudenbush and Bryk
(2002), we present a three-stage formulation of the unconditional
HLM model [34].
Visit-level model: The level-1 model for PHQ-9 or GAD-7
scores can be specified as:
yijk~p0jkzeijk ð1Þ
Here yijk represents the PHQ-9/GAD-7 score for visit i for
patient j who is treated by therapist k. The term p0jk is the patient-
level random intercept or the mean PHQ-9/GAD-7 score of
patient j in therapist k. The error term eijk represents the visit-level
random deviation of visit ijk’s score from the patient-level mean,
i.e. the random ‘occasion effect’. eijk is assumed to be normally
distributed with mean 0 and variance s2, i.e. eijk , N(0, s2).
Patient-level model: The patient-level random intercept p0jk can
in turn be modelled as an outcome that varies randomly around
the mean score of therapist k. This level-2 model can be specified
as:
Heterogeneity in Patient-Reported Outcomes: A Multilevel Analysis
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p0jk~b00kzr0jk ð2Þ
Here b00k is the mean PHQ-9/GAD-7 score for therapist k, and
r0jk represents the random deviation of patient jk’s mean from the
therapist mean, i.e. the random ‘patient effect’. As before, r0jk is
assumed to be normally distributed with mean 0 and variance tp.
Therapist-level model: The level-3 model is for the therapist-
level intercept b00k which can be specified as:
b00k~c000zu00k ð3Þ
Here c000 represents the grand mean of PHQ-9/GAD-7 scores
in the sample and b00k vary randomly around the grand mean
which is the only fixed effect in the three-level unconditional
model. u00k is the therapist-level random effect, i.e. therapist k’s
random deviation from the grand mean. This random effect is also
assumed to be normally distributed with mean 0 and variance tb.
Combined model: Using the above equations, the combined
three-level model can be represented as:
yijk~c000zu00kzr0jkzeijk ð4Þ
This is a mixed model as it contains both fixed effect c000 and
random effects u00k,r0jk,eijk.
Variance components and intra-cluster correlation
coefficient. The three-level model partitions the total variance
of the PHQ-9 scores in three components. These are: level-1
variance (s2) attributable to visit-level variability within individ-
uals; level-2 variance (tp) attributable to variability between
individuals and within therapists; and level-3 variance (tb)
between therapists. The total variance is the sum of these three
components:
var(yijk)~s
2ztpztb ð5Þ
The proportion of total variance explained by each component
can be interpreted as the correlation among observations in each
given cluster, also known as the intra-cluster correlation (ICC). In
a three level model as the one described above there are three
different ICCs:
r v,pð Þ~
s2
s2ztpztb
ð6Þ
r p,tð Þ~
tp
s2ztpztb
ð7Þ
r thð Þ~
tb
s2ztpztb
ð8Þ
where r v,pð Þ r p,tð Þ and r thð Þ represent the proportion of total
variance explained by within patient variability, within therapist
variability and between therapists variability respectively. For the
current analysis, we are primarily interested in the therapist-level
ICC r thð Þ.
Conditional model. The unconditional model (described
earlier) allows estimation of the variance associated with each level.
Part of this variance in PHQ-9/GAD-7 scores can be explained by
covariates. Hence, we estimate two conditional models:
a) Conditional model with quintiles of baseline PHQ-9/GAD-7
score (lowest quintile used as the reference category), age
(centred on mean) and gender as covariates.
b) The above model plus the following fixed effects variables:
visit number for each outcome score (continuous variable);
and time since the baseline visit in weeks (continuous
variable).
The conditional model can be represented as:
yijk~c000z
Xp~q
p~1
cpWpijkzu00kzr0jkzeijk ð9Þ
Here cp represents the coefficients on covariates p nested within
patients. The models were estimated using fixed effects at level one
and random intercepts for levels 2 (patients) and 3 (therapists). The
ICC was calculated to estimate the variance explained at each
level.
Sensitivity analysis. Three sensitivity analyses were con-
ducted. Firstly, the three-level unconditional HLM analysis for
PHQ-9 and GAD-7 was repeated using full sample, including
treatment completers and non-completers (i.e. those who dropped
out or were stepped-up). Secondly, the three-level unconditional
HLM analysis was conducted using only the patients with baseline
PHQ-9 score $10 (criteria for depression) and baseline GAD-7
score $8 (criteria for generalised anxiety disorder) respectively.
This was done to evaluate whether the variance attributable to the
therapist level is different in the subsample that screened positive
for a clinically significant depressive or anxiety disorder (defined
based on PHQ-9/GAD-7 thresholds). Finally, following the
argument by Wampold and Bolt (2006) [8], we evaluated the
robustness of our results by using two-level unconditional and
conditional HLM models whereby level-1 was defined as the
change score for each patient (i.e. baseline score minus final score
for PHQ-9 or GAD-7) and level-2 represented patients nested
within therapists. The conditional model included age, gender,
baseline severity, total number of visits and total weeks in therapy
as covariates. As explained above, the focus is on estimating the
variance attributable to the therapist-level.
Results
Descriptive statistics
There were 26,177 patients referred to the service during 2008–
2010 of which 6,583 patients were allocated to low-intensity
psychological interventions based on initial screening. Of these,
2,210 patients had at least one follow-up measure available (either
PHQ-9 or GAD-7) after the initial (screening) consultation. Of
these, 1,376 patients had completed treatment. There were 38
practitioners who provided low-intensity therapy with mean
number of patients per therapist equal to 36.2 (SD = 25.5; range
1–109, with five therapists with ,10 patients).
Heterogeneity in Patient-Reported Outcomes: A Multilevel Analysis
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The mean age of patients in the sample was 39.5 (SD = 14.6),
the proportion of females was 36.4% and the ethnicity was
predominantly white (white: 71.1%; non-white: 5.4%; not known:
23.5%). At patient-level, the mean baseline score (an indicator of
symptom severity) in the sample was 11.4 (SD = 5.7) on the PHQ-
9 scale and 10.5 (SD = 5.1) on the GAD-7 scale (see Table 1).
Based on the commonly used clinical threshold scores of $10 for
PHQ-9 and $8 for GAD-7, 51% patients could be classed as
depressed at baseline and 59% as having an anxiety disorder (note:
the two conditions often co-existed). Clinical assessment data
indicated that the three most commonly recorded primary
diagnoses in this sample were depression (37.4%), generalised
anxiety disorder (22.7%) and mixed anxiety and depressive
disorder (27.9%), with other conditions being less prevalent. At
therapist-level, the mean baseline score was 11.4 (SD = 1.1) on the
PHQ-9 scale and 10.5 (SD = 0.9) on the GAD-7 scale. The small
standard deviation in relation to the mean suggests little variation
in baseline severity between therapists [PHQ-9 (p = 0.31) and
GAD-7 (p = 0.43)]. This descriptive evidence suggests that
allocation of patients to therapists was quasi-random; in other
words, there was little evidence of systematic selection of patients
at therapist-level.
Patients attended, on average, 5.2 sessions each (SD = 2.2) and
at the end of the therapy had a mean PHQ-9 score of 5.9
(SD = 5.5) and GAD-7 score of 5.4 (SD = 4.7). Figure 1 presents a
scatterplot of session-by-session PHQ-9 scores (up to 10 sessions) of
a randomly selected sub-sample from the dataset. The figure
shows that scores within individuals are highly correlated. A
similar clustering pattern was observed in GAD-7 scores (not
presented here).
As described above, we also evaluated the patient-level change
score (on PHQ-9 and GAD-7 scales separately) over therapists. In
the overall sample, the mean patient-level change score on PHQ-9
was 5.5 (SD = 5.5) and on GAD-7 was 5.2 (SD = 5.1). At therapist-
level, the mean change score for patients was 5.4 (SD = 1.1) on
PHQ-9 and 5.2 (SD = 1.0) on GAD-7. Figure 2 presents a box plot
to explore the distribution of change scores in PHQ-9 within and
between therapists. The figure shows that, on average, all
therapists had improvement in patient-level PHQ-9 scores,
although a small number of patients within most therapists had
worse scores at the time of discharge. Crucially, the interquartile
range of change scores for all therapists overlapped with each
other, which denotes little variation between them. A similar
distribution of change scores was observed for GAD-7 scores (not
presented here).
Three-level unconditional analysis
The unconditional HLM model decomposed the total variation
in patient-level health outcomes (i.e. PHQ-9 and GAD-7 scores)
into variation explained by therapists (i.e. between therapist
variance tb), variation explained by patients (i.e. between patient
variance,tp) and the residual variance (i.e. within patient varice,
s2). Table 1 reports the variance explained at each level and the
associated ICC coefficients (i.e. the proportion of variance at each
level). The analysis found that of the total variation in patient
reported outcomes only around 1% was explained by the therapist
level (ICC: PHQ-9 = 1.0%; GAD-7 = 0.9%). The largest share of
the total variance was explained at patient level, i.e. between-
patient heterogeneity accounted for 57% and 54% of the total
variance in PHQ-9 and GAD-7 respectively). This compliments
the observation in Figure 1 which showed that scores within
individuals were highly correlated. This analysis suggests that, in
this cohort of low intensity interventions, only a small proportion
of the variation in outcomes can be attributed to therapists. In
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other words the therapist effect is very small, which would indicate
comparable and fairly uniform average outcomes between
different therapists.
Bayesian empirical predictions were used to predict values of
random intercepts for each therapist. The random intercepts
represent the relative effectiveness of each therapist in improving
health outcomes (either PHQ-9 or GAD-7) compared to the
Figure 1. Scatterplot of session-by-session PHQ-9 scores of randomly drawn patients.
doi:10.1371/journal.pone.0099658.g001
Figure 2. Boxplot of patient-level change scores (difference between baseline and final scores) on the PHQ-9 scale across
therapists.
doi:10.1371/journal.pone.0099658.g002
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average therapist in the sample. The therapist random intercepts
are ranked and presented with their 95% CI in Figure 3
(caterpillar plot). Therapists with better than average outcomes
have negative intercepts and hence are in the bottom left corner of
the plot and the lowest performing therapists in the sample have
positive intercepts and are in the top left. The 95% CI of all
random intercepts cross zero which suggests that therapists are not
statistically significantly different from the average therapist in the
group. Moreover, all therapist-level random intercepts overlap
which corroborates the finding that there was no evidence of
statistically significant differences in performance between thera-
pists.
Three-level conditional analysis
The conditional multilevel models control for imbalance in
patient-level covariates and attribute the remaining variance to the
three levels. The first conditional model included fixed effects
variables representing quintiles of baseline PHQ-9/GAD-7 scores,
age and gender. As expected, patients in quintiles with higher
baseline scores (or more severe symptom severity) were found to
have higher scores at successive visits (compared to patients in
lower baseline quintiles). Patient’s age and gender were not found
to have a statistically significant relationship with health outcomes.
More importantly, the ICC for therapist-level was 0.4% and 0.6%
in PHQ-9 and GAD-7 analyses respectively (Table 2), and most of
the remaining variance was attributable to between-patient
heterogeneity and within-patient random error. Notice, however,
that the therapist random effect is statistically non-significant at
5% in the PHQ-9 model but significant in the GAD-7 model.
In the second conditional model, we added (in addition to the
covariates in the above model) fixed effects dummy variables for
each visit, except the first therapy visit (reference category) to
explicitly control for changes in outcomes over the course of
treatment. The results were similar to earlier models and the ICC
was found to be ,1% for therapist level in both models (Table 2).
Sensitivity analyses
To evaluate the robustness of our findings, three types of
sensitivity analyses were conducted [Tables 3 and 4]. The first
analysis included full sample of patients (including non-completers
of treatment) and the second analysis included only those patients
with PHQ-9 scores $10 or GAD-7 score $8 (i.e. patients with
baseline scores above the thresholds for depression or anxiety
disorders). These analyses found that the variance explained at the
therapist level was only between 0.2% and 1.2%. A further
sensitivity analysis explored variance attributable to therapists in
two-level unconditional and unconditional analyses (i.e. patient-
level change score nested within therapists) and found therapist-
level ICC to be between 0% and 1.3% for the PROMs.
Discussion
This is the first large study in a naturalistic low-intensity
psychotherapy setting that evaluated the contribution of therapists
in variability of patient-reported outcome measures. The study
had a sample size of 1,376 primary care patients treated by 38
therapists (an average of 36 patients per therapist). The study used
three-level hierarchical linear model to estimate therapist effects,
but also evaluated two-level model in a sensitivity analysis. The
analysis was conducted using the overall sample, and, to assess the
robustness of results, using a sub-sample with initial severity above
Figure 3. Caterpillar plot of predicted therapist-level random intercept and 95% CI versus average performance benchmark.
doi:10.1371/journal.pone.0099658.g003
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the threshold scores for depression or anxiety based on PHQ-9 or
GAD-7 scores, respectively.
This analysis of therapist effects in routine low intensity
psychological interventions found TE estimates in the region of
0% to 1.3%. While statistically significant, these estimates were
substantially smaller than those typically reported in more
traditional high-intensity psychotherapeutic interventions
(e.g.,5% average TE estimate reported by Baldwin & Imel, 2013
[18]. The results are, however, consistent with the only previous
study of therapist effects in low-intensity treatments [23]. Our
results suggest that TE are less prominent in brief low intensity
interventions.
However, as outlined in the introduction, TE estimates can be
influenced by a range of methodological and sample character-
istics. It is therefore important to first examine if study design and
data analysis methods may account for the small observed
therapist effects in this study. While the main analysis used a
three-level hierarchical model (consistent with previously pub-
lished studies), the analysis was repeated using a two-level model
(using only pre- and post-treatment scores) in a sensitivity analysis;
this analysis also resulted in small (,1%) though statistically
significant TE estimates. Therefore the results seem robust to
analytical methods and are unlikely to be an artefact of the type of
HLM used.
The current study used data from a large, naturalistic cohort. A
number of authors have recommended this design as the most
appropriate one to identify therapist effects (e.g.[10,14,19] and
large effects have been found in a number of such designs (e.g.
[9,10,14,15]. The review by Baldwin and Imel (2013), in fact,
found that naturalistic cohorts reported significantly larger
therapist effects compared to tightly controlled randomised
controlled trials (7% vs. 3%) [18]. This aspect of the design,
therefore, is also unlikely to account for the small TE estimates.
This study used depression and anxiety outcome measures
which broadly matched the clinical diagnosis of patients in the
sample. It could be speculated that these measures may not be
sensitive enough to capture important variations in effect across
caseloads. However, the existing literature reveals large TE
estimates using much more generic measures of effect such as
the Global Assessment of Functioning, Global Distress Scale, etc
[18]. Furthermore, the measures applied in this study have been
shown to be sensitive enough to reveal considerable variations in
outcome when comparing outcome estimates clustered by specific
psychological services (e.g. see [35]). It therefore seems unlikely
that the choice of outcome measures entirely provides an
alternative explanation for the small therapist effects found in this
study.
Although the present results are unlikely to be artefacts of data
analysis methods, alternative explanations for the modest TE may
include the influence of patient, therapist and treatment charac-
teristics in a low-intensity psychotherapy setting. Consistent with
Kim et al. (2006) [6], our sensitivity analyses provide some
evidence that baseline severity is modestly associated with the
magnitude of TE, since these estimates increased marginally once
we excluded cases with sub-clinical baseline scores. Saxon and
Barkham (2012) offer a potential clinical interpretation for this
association [22]. In an analysis of a large naturalistic cohort of
more than 10,000 patients treated by over 100 therapists, they
found that greater severity of symptoms was associated with
increased TE, such that higher severity and risk was associated
with poorer outcomes. Since low intensity treatments are usually
offered to patients with mild-to-moderate mental health problems
with relatively low risk factors this may naturally attenuate the
extent of TE. Besides initial case severity, other characteristics of
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case complexity (e.g., level of co-morbidity, axis II difficulties) or
changes in medication use may influence TE estimates. However,
because IAPT routine data does not include measures of case
complexity or medication use, we could not explore the influence
of these characteristics. Therefore, it is possible that both the low
initial severity and case complexity of the low-intensity sample
have contributed to the small TE observed in this study.
As described earlier, there was substantial heterogeneity in
terms of the diagnoses and presenting problems of clients in this
sample. As others have argued [18], it is likely that large within-
therapist variability resulting from clinical heterogeneity may
overshadow between-therapist variability. In other words, out-
come differences between therapists are found to be less significant
compared to the wide variation in outcomes within therapists. In
this study, the within-therapist (patient-level) variability accounted
for most of variance in final treatment outcome (54–57% in the
unconditional model, 37–39% in the conditional model).
Another plausible explanation for the modest TE in this sample
relates to the level of standardisation of clinical practice that is
typical of this cohort of low intensity therapists. Low intensity
therapists in the English IAPT programme are trained to offer
brief, structured and highly standardised interventions based on
common bibliographic materials, and typically work under
considerable levels of case-management scrutiny [30,36]. This,
in turn, reduces heterogeneity of clinical practice. High levels of
standardisation of treatment such as adherence to treatment
manuals have been shown to attenuate TE [2,10], and TE
estimates from tightly controlled efficacy studies also tend to be
smaller [18]. The only other study examining TE in low intensity
treatments [23] also applied highly standardised interventions
relying on computerized CBT. It remains to be seen whether the
accumulation of future studies examining TE in low intensity
therapy confirm the standardisation of treatment as an important
determinant of between-therapist variance.
Clinical implications
This study concurs with prior evidence on low-intensity
psychotherapy that a small proportion of variation in patient
outcomes can be attributed to the therapist level, and that
between-therapist variability is very modest by comparison to that
observed in conventional high-intensity psychotherapies. The
findings of this study suggest that when therapists have similar
level of training, work under regular supervision and follow pre-
specified treatment protocols to deliver low-intensity interventions,
there is likely to be less variability in outcomes between therapists.
However, it is quite possible that TE estimates could be larger in
other services due to variability in experience, supervision and
monitoring procedures. Moreover, the findings of low-intensity
psychotherapy for patients with less severe common mental health
conditions may not apply to outcomes in severe mental health
conditions where there tends to be greater variability in baseline
severity. Therefore, the well-established practice of systematic
collection and monitoring of patient outcomes at therapist-level as
means of quality control is still likely to be important, especially in
less standardised services. Lessons from the wider literature in this
field suggest that quality control strategies should pay particular
attention to cases with high baseline severity and risk, since these
cases seem more liable to poor outcomes and may require
matching to highly skilled ‘outlier’ therapists [22]. Providing
feedback about such ‘risk cases’ to the relevant therapists may in
itself be a useful method to improve the quality of treatment and
outcomes for some patients [37,38].
It is clear that not every patient benefits from treatment (this
applies equally to low and high intensity treatments); however, this
study has shown that patient-level variability is the key factor that
explains variation in outcomes. This implies that low-intensity
therapists should be interested in understanding patient heteroge-
neity to reduce variability in outcomes. Future studies could, for
example, investigate which patient characteristics (besides the ones
investigated here) can explain within-therapist variability to allow
more patient-centred therapeutic approaches to emerge.
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